Testing DARE-HPV to Clear Persistent HPV Infection
Treatments studied
Part of Infections clinical trials.
This study tests whether DARE-HPV, a new treatment, can help your body clear a persistent human papillomavirus (HPV) infection that hasn't gone away on its own. HPV is a common virus; persistent infection with certain high-risk types can lead to cervical cancer, so clearing it early may prevent future problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a premenopausal woman aged 22–50 years old
- You have tested positive for high-risk HPV at least twice over 12+ months (showing the infection persists)
- You have no serious medical conditions and are generally in good health
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You can commit to avoiding vaginal intercourse, douching, tampons, and condoms for specific periods around treatment
- You do not have active vaginal infections (gonorrhea, chlamydia, bacterial vaginosis, yeast, or trichomoniasis) or HIV/hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
This trial tests an experimental drug called NWRD09 for women with long-lasting HPV type 16 infection that hasn't gone away. The goal is to see if it can help clear the virus and prevent precancerous changes from becoming cancer.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This trial tests an experimental treatment called NWRD09 for women who have had a persistent HPV 16 infection for at least 12 months. The goal is to see if it can clear the virus and prevent cervical changes.
This early (Phase 1) study tests a new treatment for people with long-lasting mild abnormal Pap test results (ASC-US or LSIL) who also have HPV16 found on testing. It aims to find out whether the treatment can be given safely and may affect the HPV and abnormal cell changes.
Hear when a new Human Papilloma Virus (HPV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.